B. Aronson et al., SYNTHESIS AND LIGAND-BINDING OF ETA(6)-(2-BETA-CARBOMETHOXY-3-BETA-PHENYLTROPANE) TRANSITION-METAL COMPLEXES, Journal of medicinal chemistry, 39(7), 1996, pp. 1560-1563
The transition metal complexes [eta(6)-(2 beta-carbomethoxy-3 beta-phe
nyltropane)]tricarbonylchromium (3) and [eta(6)-(2 beta-carbomethoxy-3
ta(5)-(phentamethylcyclopentadienyl)]ruthenium(II) triflate (4) were
synthesized from 2 beta-carbomethoxy-3 beta-phenyltropane (2, WIN 35,0
65) to further elucidate the influence of substituents on the 3 beta-a
ryl on the affinity of the ligand for cocaine-binding sites at the dop
amine transporter. The compounds were tested for their ability to disp
lace bound [H-3]WIN 35,428 (5) from rat caudate putamen tissue and for
their ability to inhibit [H-3]dopamine uptake. The binding affinity f
or 3 was a-fold greater than those observed for cocaine (1) and 2, whi
le the binding affinity for 4 was found to be 100-fold less than those
of 1 and 2. In addition, 3 was equipotent with 1 and 2 in [H-3]dopami
ne uptake inhibition studies, while 4 was 10-fold less potent. The pot
encies of the complexes 3 and 4 correlated; well with the structure-ac
tivity relationships of other 2 beta-carbomethoxy-3 beta-aryltropane d
erivatives. These data further support a pharmacophore model in which
the region occupied by the aryl ring is a lipophilic pocket with elect
ropositive character.